(1)要約中間連結損益計算書

(単位:百万円)

 

前中間連結会計期間

(自  2023年4月1日

  至  2023年9月30日)

当中間連結会計期間

(自  2024年4月1日

  至  2024年9月30日)

売上収益

2,101,707

2,384,028

売上原価

664,696

781,265

販売費及び一般管理費

501,065

538,312

研究開発費

346,687

344,027

製品に係る無形資産償却費及び減損損失

369,665

305,245

その他の営業収益

9,874

13,933

その他の営業費用

110,240

78,537

営業利益

119,230

350,576

 

 

 

金融収益

24,312

34,793

金融費用

106,095

128,145

持分法による投資損益

1,607

1,247

税引前中間利益

39,053

255,976

法人所得税費用

2,382

68,570

中間利益

41,436

187,406

 

 

 

 

 

 

中間利益の帰属

 

 

親会社の所有者持分

41,365

187,294

非支配持分

71

112

合計

41,436

187,406

 

 

 

 

 

 

1株当たり中間利益(円)

 

 

基本的1株当たり中間利益

26.51

118.85

希薄化後1株当たり中間利益

26.29

117.11

 

 

 

 

E00919 45020 武田薬品工業株式会社 Takeda Pharmaceutical Company Limited 四半期第7号参考様式 [IFRS](連結)(一般2Q) IFRS true cte 2024-04-01 2024-09-30 Q2 2025-03-31 2023-04-01 2023-09-30 2024-03-31 1 false false false 45020 2024-10-31 45020 2024-09-30 45020 2024-09-30 jpigp_cor:CapitalSurplusIFRSMember 45020 2024-09-30 jpigp_cor:EffectivePortionOfCashFlowHedgesIFRSMember 45020 2024-09-30 jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember 45020 2024-09-30 jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember 45020 2024-09-30 jpigp_cor:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember 45020 2024-09-30 jpigp_cor:NonControllingInterestsIFRSMember 45020 2024-09-30 jpigp_cor:OtherComponentsOfEquityIFRSMember 45020 2024-09-30 jpigp_cor:RemeasurementsOfDefinedBenefitPlansIFRSMember 45020 2024-09-30 jpigp_cor:RetainedEarningsIFRSMember 45020 2024-09-30 jpigp_cor:ShareCapitalIFRSMember 45020 2024-09-30 jpigp_cor:TreasurySharesIFRSMember 45020 2024-09-30 tse-scediffr-45020:HedgingCostIFRSMember 45020 2024-04-01 2024-09-30 45020 2024-04-01 2024-09-30 jpigp_cor:CapitalSurplusIFRSMember 45020 2024-04-01 2024-09-30 jpigp_cor:EffectivePortionOfCashFlowHedgesIFRSMember 45020 2024-04-01 2024-09-30 jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember 45020 2024-04-01 2024-09-30 jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember 45020 2024-04-01 2024-09-30 jpigp_cor:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember 45020 2024-04-01 2024-09-30 jpigp_cor:NonControllingInterestsIFRSMember 45020 2024-04-01 2024-09-30 jpigp_cor:OtherComponentsOfEquityIFRSMember 45020 2024-04-01 2024-09-30 jpigp_cor:RemeasurementsOfDefinedBenefitPlansIFRSMember 45020 2024-04-01 2024-09-30 jpigp_cor:RetainedEarningsIFRSMember 45020 2024-04-01 2024-09-30 jpigp_cor:ShareCapitalIFRSMember 45020 2024-04-01 2024-09-30 jpigp_cor:TreasurySharesIFRSMember 45020 2024-04-01 2024-09-30 tse-scediffr-45020:HedgingCostIFRSMember 45020 2023-09-30 45020 2023-09-30 jpigp_cor:CapitalSurplusIFRSMember 45020 2023-09-30 jpigp_cor:EffectivePortionOfCashFlowHedgesIFRSMember 45020 2023-09-30 jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember 45020 2023-09-30 jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember 45020 2023-09-30 jpigp_cor:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember 45020 2023-09-30 jpigp_cor:NonControllingInterestsIFRSMember 45020 2023-09-30 jpigp_cor:OtherComponentsOfEquityIFRSMember 45020 2023-09-30 jpigp_cor:RemeasurementsOfDefinedBenefitPlansIFRSMember 45020 2023-09-30 jpigp_cor:RetainedEarningsIFRSMember 45020 2023-09-30 jpigp_cor:ShareCapitalIFRSMember 45020 2023-09-30 jpigp_cor:TreasurySharesIFRSMember 45020 2023-09-30 tse-scediffr-45020:HedgingCostIFRSMember 45020 2024-03-31 45020 2024-03-31 jpigp_cor:CapitalSurplusIFRSMember 45020 2024-03-31 jpigp_cor:EffectivePortionOfCashFlowHedgesIFRSMember 45020 2024-03-31 jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember 45020 2024-03-31 jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember 45020 2024-03-31 jpigp_cor:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember 45020 2024-03-31 jpigp_cor:NonControllingInterestsIFRSMember 45020 2024-03-31 jpigp_cor:OtherComponentsOfEquityIFRSMember 45020 2024-03-31 jpigp_cor:RemeasurementsOfDefinedBenefitPlansIFRSMember 45020 2024-03-31 jpigp_cor:RetainedEarningsIFRSMember 45020 2024-03-31 jpigp_cor:ShareCapitalIFRSMember 45020 2024-03-31 jpigp_cor:TreasurySharesIFRSMember 45020 2024-03-31 tse-scediffr-45020:HedgingCostIFRSMember 45020 2023-04-01 2023-09-30 45020 2023-04-01 2023-09-30 jpigp_cor:CapitalSurplusIFRSMember 45020 2023-04-01 2023-09-30 jpigp_cor:EffectivePortionOfCashFlowHedgesIFRSMember 45020 2023-04-01 2023-09-30 jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember 45020 2023-04-01 2023-09-30 jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember 45020 2023-04-01 2023-09-30 jpigp_cor:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember 45020 2023-04-01 2023-09-30 jpigp_cor:NonControllingInterestsIFRSMember 45020 2023-04-01 2023-09-30 jpigp_cor:OtherComponentsOfEquityIFRSMember 45020 2023-04-01 2023-09-30 jpigp_cor:RemeasurementsOfDefinedBenefitPlansIFRSMember 45020 2023-04-01 2023-09-30 jpigp_cor:RetainedEarningsIFRSMember 45020 2023-04-01 2023-09-30 jpigp_cor:ShareCapitalIFRSMember 45020 2023-04-01 2023-09-30 jpigp_cor:TreasurySharesIFRSMember 45020 2023-04-01 2023-09-30 tse-scediffr-45020:HedgingCostIFRSMember 45020 2023-03-31 45020 2023-03-31 jpigp_cor:CapitalSurplusIFRSMember 45020 2023-03-31 jpigp_cor:EffectivePortionOfCashFlowHedgesIFRSMember 45020 2023-03-31 jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember 45020 2023-03-31 jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember 45020 2023-03-31 jpigp_cor:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember 45020 2023-03-31 jpigp_cor:NonControllingInterestsIFRSMember 45020 2023-03-31 jpigp_cor:OtherComponentsOfEquityIFRSMember 45020 2023-03-31 jpigp_cor:RemeasurementsOfDefinedBenefitPlansIFRSMember 45020 2023-03-31 jpigp_cor:RetainedEarningsIFRSMember 45020 2023-03-31 jpigp_cor:ShareCapitalIFRSMember 45020 2023-03-31 jpigp_cor:TreasurySharesIFRSMember 45020 2023-03-31 tse-scediffr-45020:HedgingCostIFRSMember iso4217:JPY iso4217:JPY xbrli:shares xbrli:pure